Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.
Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.
Multidrug-resistant (MDR) pathogens that cause pneumonia
Symposium Chairs: S. Aliberti (Misinto, Italy), J. Chalmers (Dundee, United Kingdom)
Aims: The aims of this session are to:
- Understand the changing epidemiology of pneumonia and the increase in drug-resistant pathogens that has been reported internationally. For this classification system for pneumonia, including community-acquired pneumonia (CAP), hospital-CAP (HCAP), and hospital-acquired pneumonia (HAP) will be described along with how this classification reflects aetiology. The importance of immunosuppression will be emphasised.
- Identify risk factors for MDR pathogens in patients with pneumonia and to learn about new ways of identifying patients at risk of MDR pathogens;
- Understand the importance of MDR pathogens in intensive care unit (ICU)-acquired pneumonia and the approach to therapy; and,
- Discuss the importance of methicillin-resistant staphylococcus aureus (MRSA) as a cause of CAP/HAP and the role of virulence factors and resistance genes in the colonisation, clinical presentation and spread of this organism.